Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
BUT-3-enyl-[5-(4-chloro-phenyI )– [1 , [–thiadiazin– yl idene]–amine is a synthetic small molecule belonging to the class of organic compounds known as chlorobenzenes and thiadiazines. It has a molecular formula of C13H14ClN3S and a molecular weight of approximately 279.79 g/mol. The compound is listed in chemical databases such as DrugBank (DB08028), ChemSpider (3826370), and PubChem (4636204). There are no approved medical indications or clinical trials associated with this compound; it is considered experimental and there is no information available regarding its mechanism of action or therapeutic use[1][2][8]. No developer or manufacturer has been identified for this molecule.
- Other names
- N-(3-buten-1-yl)-5-(4-chlorophenyl)-6H-1,3,4-thiadiazin-2-amineN-(3-buten-1-yl)-5-(4-chlorphenyl)-6H-1,3,4-thiadiazin-2-amino(2Z)-N-(but-3-en-1-yl)-5-(4-chlorophenyl)-3,6-dihydro-2H-1,3,4-thiadiazin-2-imineN-[(2Z)-5-(4-chlorophenyl)-3,6-dihydro-l , 3 , 4-thiadiazin -2 - ylidene ] but - 3 - en - l - amine
Beyond the preview
Go deeper on BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE.